UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30,
2023
OR
☐ TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission File Number 001-41081
Crescera Capital Acquisition Corp.
(Exact name of registrant as specified in its
charter)
Cayman Islands | | N/A |
(State or other jurisdiction of
incorporation or organization) | | (I.R.S. Employer Identification Number) |
| | |
Rua Aníbal de Mendonça, 27, 2nd floor,
Rio de Janeiro, RJ, Brazil | | 22410-050 |
(Address of principal executive offices) | | (Zip Code) |
+55 (21) 3687-1500 |
Registrant’s Telephone Number, Including Area Code |
|
Not applicable |
(Former name, former address and former fi scal year, if changed since last report) |
Title of Each Class | | Trading Symbol(s) | | Name of Each Exchange on Which Registered |
Class A ordinary shares, par value $0.0001 per share | | CREEF | | (1) |
| | | | |
Redeemable warrants, each one whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | | CRWWF | | (1) |
| | | | |
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant | | CREUF | | (1) |
(1) | On June 30, 2023, the Company received a written notice from
the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s securities
(units, ordinary shares, warrants, and rights) would be subject to suspension and delisting from The Nasdaq Global Market at the opening
of business on July 11, 2023 due to the Company’s non-compliance with certain Nasdaq Listing Rules. As a result, the Company’s
securities trade on the OTC Market. |
Indicate
by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant
was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer ☐ | Accelerated filer ☐ |
Non-accelerated filer ☒ | Smaller reporting company ☒ |
Emerging growth company ☒ | |
If
an emerging growth company, indicate by the check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As
of November 8, 2023, there were 151,426 Class A ordinary shares, par value $0.0001 per share and 6,708,333 Class B ordinary shares,
par value $0.0001 per share, issued and outstanding, respectively.
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the registrant
has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent
to the distribution of securities under a plan confirmed by a court. Yes ☐ No ☐
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of
each of the issuer’s classes of common stock, as of the latest practicable date.
TABLE OF CONTENTS
PART I – FINANCIAL INFORMATION
Item 1. Condensed Financial Statements
Crescera Capital Acquisition Corp.
Condensed Balance Sheets
| |
September 30,
2023 | | |
December 31,
2022 | |
| |
(Unaudited) | | |
| |
Assets | |
| | |
| |
Current assets: | |
| | |
| |
Cash | |
$ | 52,704 | | |
$ | 618,891 | |
Prepaid expenses | |
| 58,603 | | |
| 273,893 | |
Total current assets | |
| 111,307 | | |
| 892,784 | |
Marketable securities held in trust account | |
| 1,971,740 | | |
| 208,242,878 | |
Total Assets | |
$ | 2,083,047 | | |
$ | 209,135,662 | |
| |
| | | |
| | |
Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 153,734 | | |
$ | 25,325 | |
Promissory note - related party | |
| 147,026 | | |
| 149,008 | |
Accrued expenses | |
| 14,816 | | |
| 140,312 | |
Total current liabilities | |
| 315,576 | | |
| 314,645 | |
Deferred underwriting fee payable | |
| 7,043,750 | | |
| 7,043,750 | |
Derivative warrant liabilities | |
| 84,892 | | |
| 624,350 | |
Total Liabilities | |
| 7,444,218 | | |
| 7,982,745 | |
| |
| | | |
| | |
Commitments and Contingencies (Note 6) | |
| | | |
| | |
Class A ordinary shares subject to possible redemption, $0.0001 par value; 151,426 and 20,125,000 shares at redemption value of approximately $12.36 and $10.34 as of September 30, 2023 and December 31, 2022, respectively | |
| 1,871,740 | | |
| 208,142,878 | |
| |
| | | |
| | |
Shareholders’ Deficit: | |
| | | |
| | |
Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of September 30, 2023 and December 31, 2022 | |
| — | | |
| — | |
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no shares issued or outstanding (excluding 151,426 and 20,125,000 shares subject to possible redemption) as of September 30, 2023 and December 31, 2022 | |
| — | | |
| — | |
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,708,333 shares issued and outstanding as of September 30, 2023 and December 31, 2022 | |
| 671 | | |
| 671 | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (7,233,582 | ) | |
| (6,990,632 | ) |
Total Shareholders’ Deficit | |
| (7,232,911 | ) | |
| (6,989,961 | ) |
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | |
$ | 2,083,047 | | |
$ | 209,135,662 | |
The accompanying notes are an integral part
of these unaudited condensed financial statements.
Crescera Capital Acquisition Corp.
Condensed Statements of Operations
(Unaudited)
| |
For the
Three Months
Ended September 30, 2023 | | |
For the
Three Months
Ended September 30, 2022 | | |
For the
Nine Months
Ended September 30, 2023 | | |
For the
Nine Months
Ended September 30, 2022 | |
Formation and operating costs | |
$ | 186,387 | | |
$ | 145,794 | | |
$ | 782,625 | | |
$ | 507,864 | |
Loss from operations | |
| (186,387 | ) | |
| (145,794 | ) | |
| (782,625 | ) | |
| (507,864 | ) |
Gain, dividends and interest on marketable securities (net), held in trust account | |
| 25,321 | | |
| 1,031,071 | | |
| 3,710,486 | | |
| 1,247,152 | |
Change in fair value of derivative warrant liabilities | |
| 895,414 | | |
| 1,919,757 | | |
| 539,458 | | |
| 12,101,744 | |
Other income | |
| 13 | | |
| 89 | | |
| 217 | | |
| 133 | |
Net income | |
$ | 734,361 | | |
$ | 2,805,123 | | |
$ | 3,467,536 | | |
$ | 12,841,165 | |
| |
| | | |
| | | |
| | | |
| | |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted | |
| 151,426 | | |
| 20,125,000 | | |
| 10,247,958 | | |
| 20,125,000 | |
Basic and diluted net income per share, Class A ordinary shares | |
$ | 0.11 | | |
$ | 0.10 | | |
$ | 0.20 | | |
$ | 0.48 | |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted | |
| 6,708,333 | | |
| 6,708,333 | | |
| 6,708,333 | | |
| 6,708,333 | |
Basic and diluted net income per share, Class B ordinary shares | |
$ | 0.11 | | |
$ | 0.10 | | |
$ | 0.20 | | |
$ | 0.48 | |
The accompanying notes are an integral part
of these unaudited condensed financial statements.
Crescera Capital Acquisition Corp.
Condensed Statements of Changes in Ordinary
Shares Subject to Possible Redemption and Shareholders’ Deficit
For the Three and Nine Months ended September
30, 2023 and 2022
(Unaudited)
| |
Ordinary Shares Subject to
Possible Redemption(1) | | |
Ordinary Shares | | |
Additional | | |
| | |
Total | |
| |
Class A | | |
Class B | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance as of December 31, 2022 | |
| 20,125,000 | | |
$ | 208,142,878 | | |
| 6,708,333 | | |
$ | 671 | | |
$ | — | | |
$ | (6,990,632 | ) | |
$ | (6,989,961 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 724,419 | | |
| 724,419 | |
Remeasurement of Class A ordinary shares subject to redemption value | |
| — | | |
| 2,316,631 | | |
| — | | |
| — | | |
| — | | |
| (2,316,631 | ) | |
| (2,316,631 | ) |
Balance as of March 31, 2023 | |
| 20,125,000 | | |
$ | 210,459,509 | | |
| 6,708,333 | | |
$ | 671 | | |
$ | — | | |
$ | (8,582,844 | ) | |
$ | (8,582,173 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 2,008,756 | | |
| 2,008,756 | |
Redemptions | |
| (19,973,574 | ) | |
| (209,981,624 | ) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
Remeasurement of Class A ordinary shares subject to redemption value | |
| — | | |
| 1,368,534 | | |
| — | | |
| — | | |
| — | | |
| (1,368,534 | ) | |
| (1,368,534 | ) |
Balance as of June 30, 2023 | |
| 151,426 | | |
$ | 1,846,419 | | |
| 6,708,333 | | |
$ | 671 | | |
$ | — | | |
$ | (7,942,622 | ) | |
$ | (7,941,951 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 734,361 | | |
| 734,361 | |
Remeasurement of Class A ordinary shares subject to redemption value | |
| — | | |
| 25,321 | | |
| — | | |
| — | | |
| — | | |
| (25,321 | ) | |
| (25,321 | ) |
Balance as of September 30, 2023 | |
| 151,426 | | |
$ | 1,871,740 | | |
| 6,708,333 | | |
$ | 671 | | |
$ | — | | |
$ | (7,233,582 | ) | |
$ | (7,232,911 | ) |
| |
Ordinary Shares Subject to
Possible Redemption(1) | | |
Ordinary Shares | | |
Additional | | |
| | |
Total | |
| |
Class A | | |
Class B | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance as of December 31, 2021 | |
| 20,125,000 | | |
$ | 205,275,000 | | |
| 6,708,333 | | |
$ | 671 | | |
$ | — | | |
$ | (19,637,026 | ) | |
$ | (19,636,355 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 6,888,974 | | |
| 6,888,974 | |
Balance as of March 31, 2022 | |
| 20,125,000 | | |
| 205,275,000 | | |
| 6,708,333 | | |
$ | 671 | | |
$ | — | | |
$ | (12,748,052 | ) | |
$ | (12,747,381 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 3,147,068 | | |
| 3,147,068 | |
Remeasurement of Class A ordinary shares subject to redemption value | |
| — | | |
| 116,081 | | |
| — | | |
| — | | |
| — | | |
| (116,081 | ) | |
| (116,081 | ) |
Balance as of June 30, 2022 | |
| 20,125,000 | | |
$ | 205,391,081 | | |
| 6,708,333 | | |
$ | 671 | | |
$ | — | | |
$ | (9,717,065 | ) | |
$ | (9,716,394 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 2,805,123 | | |
| 2,805,123 | |
Remeasurement of Class A ordinary shares subject to redemption value | |
| — | | |
| 1,048,628 | | |
| — | | |
| — | | |
| — | | |
| (1,048,628 | ) | |
| (1,048,628 | ) |
Balance as of September 30, 2022 | |
| 20,125,000 | | |
$ | 206,439,709 | | |
| 6,708,333 | | |
$ | 671 | | |
$ | — | | |
$ | (7,960,570 | ) | |
$ | (7,959,899 | ) |
The accompanying notes are an integral part
of these unaudited condensed financial statements.
Crescera Capital Acquisition Corp.
Condensed Statements of Cash Flows
(Unaudited)
| |
For the
Nine Months
Ended September 30, 2023 | | |
For the
Nine Months
Ended September 30, 2022 | |
| |
| | |
| |
Cash Flows from Operating Activities: | |
| | | |
| | |
Net income | |
$ | 3,467,536 | | |
$ | 12,841,165 | |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | | |
| | |
Gain, dividends and interest on marketable securities (net), held in trust account | |
| (3,710,486 | ) | |
| (1,247,152 | ) |
Change in fair value of derivative warrant liabilities | |
| (539,458 | ) | |
| (12,101,744 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses | |
| 215,290 | | |
| 218,847 | |
Due from Sponsor | |
| — | | |
| (2,262 | ) |
Accounts payable | |
| 128,409 | | |
| 9,046 | |
Accrued expenses | |
| (125,496 | ) | |
| 17,821 | |
Net cash used in operating activities | |
| (564,205 | ) | |
| (264,279 | ) |
| |
| | | |
| | |
Cash Flows from Investing Activities | |
| | | |
| | |
Cash withdrawn from trust account for payment to redeeming shareholders | |
| 209,981,624 | | |
| — | |
Net cash provided by investing activities | |
| 209,981,624 | | |
| — | |
| |
| | | |
| | |
Cash Flows from Financing Activities | |
| | | |
| | |
Repayments of promissory note – related party | |
| (1,982 | ) | |
| (10,561 | ) |
Redemption of Class A ordinary shares | |
| (209,981,624 | ) | |
| — | |
Net cash used in financing activities | |
| (209,983,606 | ) | |
| (10,561 | ) |
| |
| | | |
| | |
Net Change in Cash | |
| (566,187 | ) | |
| (274,840 | ) |
Cash - Beginning of period | |
| 618,891 | | |
| 961,893 | |
Cash - End of period | |
$ | 52,704 | | |
$ | 687,053 | |
| |
| | | |
| | |
Supplemental disclosure of noncash investing and financing activities: | |
| | | |
| | |
Remeasurement of Class A ordinary shares subject to redemption value | |
$ | 3,710,486 | | |
$ | 1,164,709 | |
The accompanying notes are an integral part
of these unaudited condensed financial statements.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial
Statements
Note 1. Description of Organization and Business
Operations
Crescera Capital Acquisition Corp. (the “Company”)
is a blank check company incorporated in the Cayman Islands on March 11, 2021. The Company was formed for the purpose of effecting
a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more
businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to
all of the risks associated with emerging growth companies.
On June 13, 2023, the Company received written
notification from the Nasdaq Stock Market, LLC (the “Exchange”) indicating that since the Company’s aggregate market
value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued
listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market value of its outstanding
warrants of at least $1 million (the “Notice”).
On June 30, 2023, the Company received a written
notice from the Listing Qualifications Department of Nasdaq indicating that the Company’s securities (units, ordinary shares, warrants,
and rights) would be subject to suspension and delisting from The Nasdaq Global Market at the opening of business on July 11, 2023 due
to the Company’s non-compliance with certain Nasdaq Listing Rules. On July 25, Nasdaq announced that the Company’s securities
would be delisted from the Nasdaq Global Market. As a result, the Company’s securities trade on the OTC Market.
As of September 30, 2023, the Company had
not commenced any operations. All activity from inception through September 30, 2023 relates to the Company’s formation, the
initial public offering (“Initial Public Offering” or “IPO”) as described below, and since the closing of the
Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues
until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form
of interest income on investments held in a trust account from the proceeds derived from the Initial Public Offering and non-operating
income or expense in the form of changes in the fair value of warrant liabilities.
The registration statement for the Company’s
Initial Public Offering was declared effective on November 18, 2021. On November 23, 2021, the Company consummated the Initial
Public Offering of 20,125,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold,
the “Public Shares”), including 2,625,000 additional Units to cover over-allotments (the “Over-Allotment Units”),
at $10.00 per Unit, generating gross proceeds of $201,250,000 (see Note 3).
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 10,150,000 warrants (the “Private Placement Warrants”) at a price of
$1.00 per Private Placement Warrant in a private placement to CC Sponsor LLC (the “Sponsor”) generating gross proceeds of
$10,150,000 (see Note 4).
Upon the closing of the Initial Public Offering
on November 23, 2021, an amount of $205,275,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial
Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), and was
invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with maturities
of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act
of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations, as
determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds
held in the Trust Account, as described below.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial
Statements
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Warrants,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company
will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting
securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as
an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business
Combination.
The Company will provide its holders of the outstanding
Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the
completion of a Business Combination either (i) in connection with a shareholders meeting called to approve the Business Combination
or (ii) by means of a tender offer. In connection with an initial Business Combination, the Company may seek shareholder approval of
a Business Combination at a meeting called for such purpose at which public shareholders may seek to redeem their shares, regardless
of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if a majority of
the outstanding shares voted are voted in favor of the Business Combination., if the Company seeks shareholder approval.
If the Company seeks shareholder approval of
a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s amended and restated
memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) provides that,
a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert
or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior
written consent.
The Public Shareholders will be entitled to redeem
their shares for a pro rata portion of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to
be distributed to Public Shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company
will pay to the representative of the underwriters (as discussed in Note 5). There will be no redemption rights upon the completion of
a Business Combination with respect to the Company’s warrants. These Class A ordinary shares were recorded at a redemption value
and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification
(“ASC”) Topic 480 Distinguishing Liabilities from Equity.
If a shareholder vote is not required and the
Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and
Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange
Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included
in a proxy statement with the SEC prior to completing a Business Combination.
The Company’s Sponsor agreed (a) to vote
its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business
Combination, (b) not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association with
respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company
provides dissenting Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c)
not to redeem any shares (including the Founder Shares) and Private Placement Warrants (including underlying securities) into the right
to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares
in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith)
or a vote to amend the provisions of the Amended and Restated Memorandum and Articles of Association relating to shareholders’
rights of pre-Business Combination activity and (d) that the Founder Shares and Private Placement Warrants (including underlying securities)
shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor
will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the
Initial Public Offering if the Company fails to complete its Business Combination.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial
Statements
If the Company is unable to complete a Business
Combination within 24 months from the closing of the Initial Public Offering (the “Combination Period”), the Company will
(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business
days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes
(less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions,
if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal
dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirement of applicable
law. The representative of the underwriters agreed to waive its rights to the deferred underwriting commission held in the trust account
in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will
be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event
of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the
Initial Public Offering price per Unit ($10.00).
The Sponsor agreed that it will be liable to
the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective
target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business
Combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.20 per Public Share and (ii) the
actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.20 per share
due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by
a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether
or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial
Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities
Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently
verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations. None of the Company’s officers or directors
will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
At the Extraordinary General Meeting held on
May 16, 2023, the Company’s shareholders approved the Articles Amendment to amend the Articles to extend the date from May 23,
2023 (the date which is 18 months from the closing date of the Company’s IPO of Class A ordinary shares) to November 23, 2023 (the
date which is 24 months from the closing date of the Company’s IPO), or such earlier date as determined by the Board, and to allow
the Board, without another shareholder vote, to extend the period of time to consummate the initial business combination for an additional
6 months after the Articles Extension Date on the same terms as the original extension right as contemplated by our IPO prospectus and
in accordance with the Articles, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination
Date, until May 23, 2024 (the date which is 30 months from the closing date of the Company’s IPO), or a total of twelve months
after May 23, 2023.
As a result of the Extraordinary General Meeting,
the Company’s shareholders redeemed 19,973,574 shares. As a result, $209,981,624 ($10.51 per share) was removed from the Company’s
trust account to pay such holders. Following redemptions, the Company has 151,426 Class A ordinary shares, subject to redemption outstanding.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial
Statements
Liquidity, Capital Resources and Going Concern
As of September 30, 2023, the Company had
$52,704 in cash held outside of the Trust Account and a working capital deficit of $204,269.
In order to finance transaction costs in connection
with a Business Combination, the Company’s Sponsor, or an affiliate of the Sponsor or certain of the Company’s officers and
directors may, but are not obligated to, provide the Company working capital loans (as defined in Note 5). As of September 30, 2023
and December 31, 2022, the Company had no borrowings under the Working Capital Loans.
The Company will have until November 23, 2023
to complete a Business Combination. If a Business Combination is not consummated by November 23, 2023 and an extension has not been effected
as described above, there will be a mandatory liquidation and subsequent dissolution of the Company.
The Company has incurred and expects to incur
significant costs in pursuit of its financing and acquisition plans. In connection with the Company’s assessment of going concern
considerations, management has determined that both the Company’s liquidity and liquidation deadline raise substantial doubt about
the Company’s ability to continue as a going concern within one year from the date that the financial statements are issued. There
is no assurance that the Company’s plans to consummate a Business Combination or raise additional funds will be successful within
the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note 2. Summary of Significant Accounting
Policies
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
and pursuant to the rules and regulations of the SEC.
Certain information or footnote disclosures normally
included in unaudited condensed financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the
rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes
necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the
accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary
for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited
condensed financial statements should be read in conjunction with the Company’s annual report on Form 10-K as filed with the SEC
on April 14, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of
the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public
accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive
compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote
on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial
Statements
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an
emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition
period, which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging
growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because
of the potential differences in accounting standards used.
Use of Estimates
The preparation of the unaudited condensed financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported
amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could
change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from
those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of September 30, 2023 and December 31, 2022. As of September 30, 2023 and December 31, 2022, the Company had operating
cash (i.e. cash held outside the Trust Account) of $52,704 and $618,891, respectively.
Marketable Securities in the Trust Account
As of September 30, 2023 and December 31,
2022, the Company had a total of $1,971,740 and $208,242,878 in the Trust Account held money market funds, respectively. The Company’s
portfolio of investments held in the Trust Account are comprised solely of U.S. government securities, within the meaning set forth in
Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, classified as trading securities. Trading securities
are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair
value of these securities is included in gain on marketable securities, dividends and interest held in the Trust Account in the accompanying
statement of operations. The fair value for trading securities is determined using quoted market prices in active markets.
Fair Value of Financial Instruments
The Company applies ASC Topic 820, Fair Value
Measurement (“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair
value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid
to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants
on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable
inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants
would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting
entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the
assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information
available in the circumstances.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial
Statements
The carrying amounts reflected in the balance
sheet for current assets and current liabilities approximate fair value due to their short-term nature.
GAAP specifies a three-level hierarchy that is
used when measuring and disclosing fair value. The fair value hierarchy gives the highest priority to quoted prices available in active
markets (i.e. observable inputs) and the lowest priority to data lacking transparency (i.e. unobservable inputs). An instrument’s
categorization within the fair value hierarchy is based on the lowest level of significant inputs to its valuation. The following is
a description of the three hierarchy levels.
Level 1 — Assets and liabilities with unadjusted,
quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in
active markets for identical assets or liabilities.
Level 2 — Inputs to the fair value measurement
are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable
inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
Level 3 — Inputs to the fair value measurement
are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets
or liabilities.
See Note 9 for additional information on assets
and liabilities measured at fair value.
Derivative Warrant Liabilities
The Company accounts for warrants as either equity-classified
or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance
in ASC 480 and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary
shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated
fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The Company issued 10,062,500 warrants
to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 10,150,000
Private Placement Warrants. All of the Company’s outstanding warrants are recognized as derivative liabilities in accordance with
ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair
value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change
in fair value is recognized in the statement of operations. The fair value of warrants issued in connection with the Initial Public Offering
were measured at fair value using a Monte Carlo simulation model for the Public Warrants and Private Placement Warrants.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
Offering Costs
Offering costs consist of legal, accounting,
underwriting and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Upon the
completion of the Initial Public Offering, the offering costs were allocated using the relative fair values of the Company’s Class
A ordinary shares and its warrants. The costs allocated to warrants were recognized in other expenses and those related to the Company’s
Class A ordinary shares were charged to temporary equity.
Class A Ordinary Shares Subject to Possible
Redemption
All of the 20,125,000 Class A ordinary shares
sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public
Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business
Combination and in connection with certain amendments to the Amended and Restated Memorandum and Articles of Association. In accordance
with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions
not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.
Therefore, all Class A ordinary shares have been classified outside of permanent equity. Accordingly, as of September 30, 2023 and
December 31, 2022, 151,426 and 20,125,000, respectively, Class A ordinary shares subject to possible redemption are presented at redemption
value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets, respectively.
The Company recognizes changes in redemption
value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end
of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against
additional paid-in capital (to the extent available) and accumulated deficit. The redemption value of the redeemable ordinary shares
as of September 30, 2023 increased as the income earned on the Trust Account exceeds the Company’s expected dissolution expenses
(up to $100,000). As such, the Company recorded an increase in the carrying amount of the redeemable ordinary shares of $3,710,486 for
the nine months ended September 30, 2023.
As of September 30, 2023 and December 31,
2022, the Class A ordinary shares subject to redemption reflected in the balance sheets are reconciled in the following table:
Class A ordinary shares subject to possible
redemption
Class A ordinary shares subject to possible redemption as of December 31, 2022 | |
$ | 208,142,878 | |
Plus: | |
| | |
Additional remeasurement of carrying value to redemption value as of March 31, 2023 | |
| 2,316,631 | |
Class A ordinary shares subject to possible redemption as of March 31, 2023 | |
$ | 210,459,509 | |
Plus: | |
| | |
Initial pre-extension redemption | |
| (209,981,624 | ) |
Additional remeasurement of carrying value to redemption value as of June 30, 2023 | |
| 1,368,534 | |
Class A ordinary shares subject to possible redemption as of June 30, 2023 | |
$ | 1,846,419 | |
Plus: | |
| | |
Additional remeasurement of carrying value to redemption value as of September 30, 2023 | |
| 25,321 | |
Class A ordinary shares subject to possible redemption as of September 30, 2023 | |
$ | 1,871,740 | |
Net Income Per Ordinary Share
Net income per ordinary share is computed by
dividing net income by the weighted-average number of ordinary shares outstanding during the period. The net income per share calculation
allocates income and losses shared pro rata between Class A and Class B ordinary shares. As a result, the calculated net income per share
is the same for Class A and Class B ordinary shares. The remeasurement of Class A ordinary shares subject to redemption to redemption
value is excluded from the earnings per share as the redemption value approximates fair value. Class B ordinary shares subject to forfeiture
are not considered in the calculation of diluted income per share until the forfeiture contingency has lapsed. The Company has not considered
the effect of the Public Warrants (as defined in Note 3) and Private Placement Warrants to purchase an aggregate of 20,212,500 shares
in the calculation of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
The following table reflects the calculation
of basic and diluted net income per ordinary share:
| |
For the Three Months Ended | |
| |
September 30, 2023 | | |
September 30, 2022 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net income per share: | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Net income | |
$ | 16,211 | | |
$ | 718,150 | | |
$ | 2,103,842 | | |
$ | 701,281 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 151,426 | | |
| 6,708,333 | | |
| 20,125,000 | | |
| 6,708,333 | |
Basic and diluted net income per share | |
$ | 0.11 | | |
$ | 0.11 | | |
$ | 0.10 | | |
$ | 0.10 | |
| |
For the Nine Months Ended | |
| |
September 30, 2023 | | |
September 30, 2022 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net income per share: | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Net income | |
$ | 2,095,692 | | |
$ | 1,371,844 | | |
$ | 9,630,874 | | |
$ | 3,210,291 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 10,247,958 | | |
| 6,708,333 | | |
| 20,125,000 | | |
| 6,708,333 | |
Basic and diluted net income per share | |
$ | 0.20 | | |
$ | 0.20 | | |
$ | 0.48 | | |
$ | 0.48 | |
Income Taxes
The Company complies with the accounting and
reporting requirements of ASC Topic 740, Income Taxes (“ASC 740”), which requires an asset and liability approach
to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between
the condensed financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts,
based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 also clarifies the accounting for uncertainty
in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process
for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits
to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes
accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and
no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not
aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
The Company is considered an exempted Cayman
Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.
As such, the Company’s tax provision was zero for the period presented.
The Inflation Reduction Act (“IRA”)
was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on share repurchases that occur after December 31,
2022 and introduces a 15% corporate alternative minimum tax (“CAMT”) on adjusted financial statement income. The CAMT will
be effective for the Company beginning in fiscal 2023. Currently, the Company is not expecting the IRA to have an adverse impact to our
financial statements.
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal
depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company
is not exposed to significant risks on such account.
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed
financial statements.
Note 3. Initial Public Offering
Pursuant to the Initial Public Offering, the
Company sold 20,125,000 Units, which includes the exercise by the underwriters of their over-allotment option in the amount of 2,625,000,
at $10.00 per Unit, generating gross proceeds of $201,250,000. Each Unit consisted of one share of Class A ordinary shares of the Company,
par value $0.0001 per share, and one-half of one redeemable warrant of the Company (“Public Warrant” or together with the
Private Placement Warrants, the “Warrants”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary
share at an exercise price of $11.50 per whole share (see Note 7).
Note 4. Private Placement
Simultaneously with the closing of the Initial
Public Offering, the Sponsor purchased an aggregate of 10,150,000 Private Placement Warrants at a price of $1.00 per Private Placement
Warrant (for an aggregate purchase price of $10,150,000). Each warrant is exercisable to purchase one share of the Company’s Class
A ordinary shares at a price of $11.50 per share. Certain proceeds from the sale of the Private Placement Warrants were added to the
proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the
Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares
(subject to the requirement of applicable law) and the Private Placement Warrants will expire worthless.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
Note 5. Related Party Transactions
Founder Shares
In March 2021, one of the Company’s officers
paid $25,000, to cover certain of the Company’s offering costs, in exchange for an aggregate of 5,750,000 Class B ordinary shares
(the “Class B Ordinary Shares” or “Founder Shares”), which were temporarily issued to such officer. On April
7, 2021, the Founder Shares were transferred to the Company’s Sponsor.
In October 2021, the Company effected a share
capitalization pursuant to which an additional 958,333 Founder Shares were issued for no consideration, using the existing share premium
account, resulting in an aggregate of 6,708,333 of Founder Shares outstanding. Prior to the Initial Public Offering, the Sponsor also
transferred 25,000 of the Founder Shares to each of the Company’s three independent directors.
The Founder Shares include an aggregate of up
to 875,000 shares that were subject to forfeiture by the Sponsor. The underwriter’s over-allotment opinion was exercised and these
shares are no longer subject to forfeiture. Prior to the initial investment in the Company of $25,000 by the Company’s Sponsor,
the Company had no assets, tangible or intangible. The per share purchase price of the Founder Shares was determined by dividing the
amount of cash contributed to the Company by the aggregate number of Founder Shares issued. Out of the 6,708,333 Founder Shares, 5,031,250
Founder Shares will convert into Class A ordinary shares after the initial Business Combination and 1,677,083 Founder Shares will convert
into Class A ordinary shares only to the extent the Company’s share trades at or above $12.50 per share as described in the final
prospectus.
At the Extraordinary General Meeting held on
May 16, 2023, the Company’s shareholders approved the Articles Amendment to amend the Articles to provide that the Class B Ordinary
Shares may be converted either at the time of the consummation of the Company’s initial Business Combination or at any earlier
date at the option of the holders of the Class B Ordinary Shares (where the holders of the Class B Ordinary Shares have waived any right
to receive funds from the Trust Fund). Prior to the consummation of a Business Combination or the date on which all Class B Ordinary
Shares have been converted into Class A Ordinary Shares, holders of Class A Ordinary Shares shall have no right to vote on the appointment
or removal of any Director.
Prior to the Initial Public Offering, three independent
directors purchased 25,000 Founder Shares each from the Sponsor, at their original purchase price (approximately $0.004 per share) for
a total of $280. If the director is removed from office as director, or voluntarily resigns his position with the Company before a merger,
capital stock exchange, asset acquisition, share purchase, reorganization or similar Business Combination involving the Company, all
of the director’s Class B ordinary shares shall be returned to the Sponsor. The fair value of the Founder Shares at the grant dates
was determined using an internal model using the issuance price of the Units in the Initial Public Offering as a proxy adjusting for
the value for the warrants included in the Units, for the probability the Company will consummate an initial Business Combination and
for holding costs and no rights of redemption. Valuation of the 75,000 Founder Shares granted to the directors is estimated to be $342,201
or $4.56 per share. The Company will record the fair value of the transferred shares in excess of the amount paid of $341,921 as director
compensation expense upon consummation of an initial Business Combination, in accordance with the guidance in ASC 718.
Compensation
- Stock Compensation.
The holders of the Founder Shares agreed, subject
to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (i) 180 days after
the completion of the initial Business Combination or (ii) subsequent to the initial Business Combination, the date on which the Company
completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s
shareholders having the right to exchange their ordinary shares for cash, securities or other property.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
The Founder Shares will automatically convert
into Class A ordinary shares on the first business day following the completion of the initial Business Combination, at a ratio such
that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate on an as-converted
basis, 15% of the sum of (i) the total number of all Class A ordinary shares issued and outstanding upon completion of this offering
(including the over-allotment shares as a result of the underwriter exercising its over-allotment option), plus (ii) the total number
of Class A ordinary shares issued or deemed issued or issuable upon conversion of the Founder Shares plus (iii) the total number of Class
A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein)
or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination,
excluding (x) any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued,
deemed issued, or to be issued, to any seller in the initial Business Combination, and (y) any Private Placement Warrants issued to the
Sponsor, its affiliates or any member of the Company’s management team upon conversion of working capital loans. Prior to the initial
Business Combination, only holders of Class B ordinary shares will be entitled to vote on the appointment of directors.
Promissory Note - Related Party
The Sponsor agreed to loan the Company an aggregate
of up to $250,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing, unsecured
and was due at the earlier of December 31, 2022 or the closing of the initial Business Combination. In January 2023, the loan was amended
retroactively to December 31, 2022 to become due only upon a Business Combination. As of September 30, 2023 and December 31,
2022, the Company had an outstanding balance of $147,026 and $149,008, respectively under the promissory note.
Working Capital Loans
In order to finance transaction costs in connection
with an initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors
may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes
an initial Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released
to the Company. In the event that an initial Business Combination does not close, the Company may use a portion of proceeds held outside
the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital
Loans. The Working Capital Loans would either be repaid upon consummation of an initial Business Combination or, at the lender’s
discretion, up to $2,100,000 of such Working Capital Loans may be convertible into Private Placement Warrants of the post-initial Business
Combination entity at a price of $1.00 per warrant. Except for the foregoing, the terms of such Working Capital Loans, if any, have not
been determined and no written agreements exist with respect to such loans. As of September 30, 2023 and December 31, 2022,
the Company had no borrowings under the Working Capital Loans.
Note 6. Commitments and Contingencies
Registration Rights
The holders of Founder Shares, Private Placement
Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any (and any Class A ordinary shares issuable upon
the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans), are entitled to registration
rights pursuant to a registration rights agreement that was signed prior to the consummation of the Initial Public Offering. These holders
will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides
that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until
termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.
Crescera Capital Acquisition
Corp.
Notes To The Unaudited Condensed Financial Statements
Underwriting Agreement
The Company granted the underwriters a 45-day
option to purchase up to 2,625,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting
discounts and commissions. The underwriters fully exercised the option on November 23, 2021.
The underwriters were entitled to a cash underwriting
discount of 2.0% of the gross proceeds of the Initial Public Offering, or $4,025,000 in the aggregate, which was paid upon closing of
the Initial Public Offering. In addition, the representative of the underwriters will be entitled to a deferred fee of 3.5% of the gross
proceeds of the Initial Public Offering, or $7,043,750. The deferred fee will become payable to the representative of the underwriters
from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms
of the underwriting agreement.
Note 7. Warrants
The Company accounted for the 20,212,500 Warrants
issued in connection with the Initial Public Offering (the 10,062,500 of Public Warrants and the 10,150,000 of Private Placement Warrants)
in accordance with the guidance contained in ASC 815-40 Derivatives and Hedging — Contracts in Entity’s Own Equity.
Such guidance provides that, because the Warrants do not meet the criteria for equity treatment thereunder, each Warrant must be recorded
as a liability. Accordingly, the Company classifies each Warrant as a liability at its fair value. This liability is subject to re-measurement
at each balance sheet date. With each such re-measurement, the Warrant liability will be adjusted to fair value, with the change in fair
value recognized in the Company’s condensed statement of operations.
Additionally, certain adjustments to the settlement
amount of the Private Placement Warrants are based on a variable that is not an input to the fair value of a “fixed-for-fixed”
option as defined under ASC 815-40, and thus the Private Placement Warrants are not considered indexed to the Company’s own shares
and not eligible for an exception from derivative accounting.
The accounting treatment of derivative financial
instruments requires that the Company record a derivative liability upon issuance of the warrants at the closing of the Initial Public
Offering. The Public Warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined
with the assistance of a professional independent valuation firm.
Public Warrants may only be exercised for a whole
number of shares. No fractional Public Warrants were issued upon separation of the Units and only whole Public Warrants trade. The Public
Warrants will become exercisable 30 days after the completion of a Business Combination provided that the Company has an effective registration
statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus
relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky,
laws of the state of residence of the holder (or holders are permitted to exercise their warrants on a cashless basis under certain circumstances
as a result of (i) the Company’s failure to have an effective registration statement by the 60th business day after the closing
of the initial Business Combination or (ii) a notice of redemption described under “Redemption of warrants when the price per share
of Class A ordinary shares equals or exceeds $10.00”). The Company has agreed that as soon as practicable, but in no event later
than 20 business days after the closing of its initial Business Combination, the Company will use its commercially reasonable efforts
to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the
warrants and will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing
of the Company’s initial Business Combination and to maintain a current prospectus relating to those Class A ordinary shares until
the warrants expire or are redeemed. If the shares issuable upon exercise of the warrants are not registered under the Securities Act
in accordance with the above requirements, the Company will be required to permit holders to exercise their warrants on a cashless basis.
However, no warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to
holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the
securities laws of the state of the exercising holder, or an exemption from registration is available. Notwithstanding the above, if
the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange
such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may,
at its option, require holders of Public warrants who exercise their warrants to do so on a “cashless basis” in accordance
with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect
a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register
or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
The warrants have an exercise price of $11.50
per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption
or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising
purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20
per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the board of directors
and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor
or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from
such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business
Combination on the date of the consummation of the initial Business Combination (net of redemptions) and (z) the volume weighted average
trading price of Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company
consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price
of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price,
and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of warrants for Class A ordinary shares”
and “Redemption of warrants for cash” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of
the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical
to the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees, (i) they will not be redeemable
by the Company, (ii) they (including the Class A ordinary shares issuable upon exercise of these warrants) may not, subject to certain
limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the initial Business Combination,
(iii) they may be exercised by the holders on a cashless basis and (iv) are subject to registration rights.
If a tender offer, exchange or redemption offer
shall have been made to and accepted by the holders of the Class A ordinary shares and upon completion of such offer, the offeror owns
beneficially more than 50% of the outstanding Class A ordinary shares the holder of the warrant shall be entitled to receive the highest
amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant
had been exercised, accepted such offer and all of the Class A ordinary shares held by such holder had been purchased pursuant to the
offer. If less than 65% of the consideration receivable by the holders of the Class A ordinary shares in the applicable event is payable
in the form of common equity in the successor entity that is listed on a national securities exchange or is quoted in an established
over-the-counter market, and if the holder of the warrant properly exercises the warrant within thirty days following the public disclosure
of the consummation of the applicable event by the Company, the warrant price shall be reduced by an amount equal to the difference (but
in no event less than zero) of (i) the warrant price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as
defined in the warrant agreement) minus (B) the value of the warrant based on the Black-Scholes Warrant Value for a Capped American Call
on Bloomberg Financial Markets.
Redemption of warrants when the price per
share of Class A ordinary shares equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding
warrants (except as described herein with respect to the Private Placement Warrants):
| ● | in whole and not in part; |
| ● | at a price of $0.01 per warrant; |
| ● | upon a minimum of 30 days’
prior written notice of redemption; and |
| ● | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Warrants — Redemption Procedures — Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders. |
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
The Company will not redeem the warrants as described
above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise
of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption
period. Any such exercise would not be on a cashless basis and would require the exercising warrant holder to pay the exercise price
for each warrant being exercised.
Redemption of warrants when the price per
share of Class A ordinary shares equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding
warrants:
| ● | in whole and not in part; |
| ● | at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Warrants” based on the redemption date and the “fair market value” of Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities — Warrants — Public Warrants”; and; |
| ● | if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Warrants — Redemption Procedures — Anti-dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders; and |
| ● | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Warrants — Redemption Procedures — Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |
In no event will the Company be required to net
cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates
the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will
they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly,
the warrants may expire worthless.
Note 8. Shareholders’ Deficit
Preferred shares — The Company
is authorized to issue 5,000,000 preferred shares, par value $0.0001 per share, with such designations, voting and other rights and preferences
as may be determined from time to time by the Company’s board of directors. As of September 30, 2023 and December 31,
2022, there were no preferred shares issued or outstanding.
Class A ordinary shares —
The Company is authorized to issue up to 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30,
2023 and December 31, 2022, there were no Class A ordinary shares issued and outstanding, excluding 151,426 and 20,125,000 Class
A ordinary shares subject to possible redemption as of September 30, 2023 and December 31, 2022, respectively.
Class B ordinary shares —
The Company is authorized to issue up to 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of both September 30,
2023 and December 31, 2022, there were 6,708,333 Class B ordinary shares issued and outstanding.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
Holders of the Class A ordinary shares and holders
of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders,
except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares shall have the right to vote
on the election of the Company’s directors prior to the initial Business Combination.
Note 9. Fair Value Measurements
The following table presents information about
the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023
and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value:
Description | |
Amount at
Fair Value | | |
Level 1 | | |
Level 2 | | |
Level 3 | |
September 30, 2023 (Unaudited) | |
| | |
| | |
| | |
| |
Assets | |
| | |
| | |
| | |
| |
Marketable securities held in trust account: | |
| | |
| | |
| | |
| |
Money Market investments | |
$ | 1,971,740 | | |
$ | 1,971,740 | | |
$ | — | | |
$ | — | |
Liabilities | |
| | | |
| | | |
| | | |
| | |
Warrant liability – Public Warrants | |
$ | 42,262 | | |
$ | 42,262 | | |
$ | — | | |
$ | — | |
Warrant liability – Private Placement Warrants | |
$ | 42,630 | | |
$ | — | | |
$ | — | | |
$ | 42,630 | |
December 31, 2022 | |
| | | |
| | | |
| | | |
| | |
Assets | |
| | | |
| | | |
| | | |
| | |
Marketable securities held in trust | |
| | | |
| | | |
| | | |
| | |
Money Market investments | |
$ | 208,242,878 | | |
$ | 208,242,878 | | |
$ | — | | |
$ | — | |
Liabilities | |
| | | |
| | | |
| | | |
| | |
Warrant liability – Public Warrants | |
$ | 302,881 | | |
$ | 302,881 | | |
$ | — | | |
$ | — | |
Warrant liability – Private Placement Warrants | |
$ | 321,469 | | |
$ | — | | |
$ | — | | |
$ | 321,469 | |
The Company utilized a Monte Carlo simulation
model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants as of September 30, 2023
is classified as Level 1 due to the use of an observable market quote in an active market under the ticker CRWWF on the OTC Market. The
quoted price of the Public Warrants was approximately $0.004 per warrant as of September 30, 2023. As of December 31, 2022, the
Public Warrants were traded in an active market under the ticker CRECW.
The estimated fair value of the Private Placement
Warrants, and the Public Warrants was initially determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions
related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the volatility
of its Private Placement Warrants based on implied volatility from the Company’s traded warrants and from historical volatility
of select peer company’s Class A ordinary shares that matches the expected remaining life of the warrants. The risk-free interest
rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of
the warrants. The expected life of the warrants was estimated utilizing a probability weighted approach based on the expected outcomes
of both a successful and unsuccessful business combination. The dividend rate is based on the historical rate, which the Company anticipates
remaining at zero.
Transfers to/from Levels 1, 2 and 3 are recognized
at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level
1 fair value measurement on January 14, 2022, after the Public Warrants were separately listed and traded.
Crescera Capital Acquisition Corp.
Notes To The Unaudited Condensed Financial Statements
The following table provides the significant
inputs used in the Monte Carlo simulation model to measure the fair value of the Private Placement Warrants:
| |
As of
September 30,
2023 | | |
As of
December 31,
2022 | |
Exercise Price | |
| 11.50 | | |
| 11.50 | |
Underlying share price | |
$ | 11.30 | | |
$ | 10.22 | |
Volatility | |
| — | % | |
| 5.3 | % |
Weighted Average Term to Business Combination (years) | |
| 0.91 | | |
| 1.07 | |
Risk-free rate | |
| 5.47 | % | |
| 4.71 | % |
Dividend yield | |
| 0.00 | % | |
| 0.00 | % |
The following table provides a summary of the
changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis as
of September 30, 2023:
Fair value as of December 31, 2021 | |
$ | 13,926,587 | |
Transfer of Public Warrants to Level 1 measurement | |
| (6,912,938 | ) |
Change in fair value of derivative warrant liabilities with Level 3 inputs | |
| (6,692,181 | ) |
Fair value as of March 31, 2022 | |
| 321,469 | |
Change in fair value of derivative warrant liabilities with Level 3 inputs | |
| 1,561,568 | |
Fair value as of June 30, 2022 | |
| 1,883,037 | |
Change in fair value of derivative warrant liabilities with Level 3 inputs | |
| (964,034 | ) |
Fair value as of September 30, 2022 | |
| 919,003 | |
Change in fair value of derivative warrant liabilities with Level 3 inputs | |
| (597,534 | ) |
Fair value as of December 31, 2022 | |
| 321,469 | |
Change in fair value of derivative warrant liabilities with Level 3 inputs | |
| 680,547 | |
Fair value as of March 31, 2023 | |
| 1,002,016 | |
Change in fair value of derivative warrant liabilities with Level 3 inputs | |
| (509,741 | ) |
Fair value as of June 30, 2023 | |
| 492,275 | |
Change in fair value of derivative warrant liabilities with Level 3 inputs | |
| (449,645 | ) |
Fair value as of September 30, 2023 | |
$ | 42,630 | |
Note 10. Subsequent Events
The Company evaluated subsequent events and transactions that occurred
after the balance sheet date up to the date that the financial statements were issued.
Item 2. Management’s Discussion and
Analysis of Financial Condition and Results of Operations.
References in this report (the “Quarterly
Report”) to “we,” “us” or the “Company” refer to Crescera Capital Acquisition Corp. References
to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor”
refer to CC Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should
be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly
Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve
risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and
Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to
differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly
Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and
Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management
for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,”
“intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify
such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s
current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ
materially from the events, performance and results discussed in the forward-looking statements. For information identifying important
factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to
the Risk Factors section of the Company’s annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the
“SEC”) and Part II, Item 1A “Risk Factors” below. The Company’s securities filings can be accessed on the
EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims
any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events
or otherwise.
Overview
We are a blank check company formed under the
laws of Cayman Islands on March 11, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination
using cash from the proceeds of the IPO and the sale of the Private Placement Warrants, and forward purchase securities, our capital
stock, debt, or a combination of cash, stock, and debt.
Our sponsor is CC Sponsor LLP, a Cayman Islands
limited liability company. Our registration statement for the IPO became effective on November 18, 2021. We consummated the IPO of 20,125,000
units on November 23, 2021. Each unit consisted of one Class A ordinary shares and one-half of one redeemable warrant (“Public
Warrant”), including the issuance of 2,625,000 Units as a result of the underwriter’s (the “Underwriter”) exercise
of its over-allotment option (“Over-allotment Option”) in full. Each Unit consists of one Class A ordinary share of the Company,
par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one redeemable warrant of the Company (each
whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50
per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $201,250,000.
We incurred $11,068,750 in underwriting fees (inclusive of $7,043,750 in deferred underwriting fees) as well as $720,328 of other offering
costs.
Simultaneously with the closing of the IPO on
November 23, 2021, we completed the closing of the private placement of an aggregate 10,150,000 private placement warrants at a price
of $1.00 per private placement warrant to the sponsor, generating proceeds of $10,150,000.
Upon the closing of the IPO, the over-allotment and the private placements,
$205,275,000 ($10.20 per unit) of the net proceeds of the sale of the units in the IPO, the over-allotment and the private placement
warrants were placed in the Trust Account with Continental Stock Transfer & Trust Company acting as trustee and invested in United
States government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries
and meeting certain conditions under Rule 2a-7 under the Investment Company Act, as determined by us, until the earlier of: (i) the completion
of a business combination and (ii) the distribution of the trust account as described below.
Our management and our board of directors have broad discretion with
respect to the specific application of the net proceeds of the IPO, the over-allotment and the sale of private placement warrants, although
substantially all of the net proceeds are intended to be applied generally toward consummating a business combination.
If we have not completed our initial business
combination within 24 months from the closing of the IPO (the “Combination Period”), we will (i) cease all operations except
for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public
shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000
of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely
extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any);
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the
board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law
to provide for claims of creditors and the requirements of other applicable law.
At the Extraordinary General Meeting held on
May 16, 2023, the Company’s shareholders approved the Articles Amendment to amend the Articles to extend the date from May 23,
2023 (the date which is 18 months from the closing date of the Company’s IPO of Class A ordinary shares) to November 23, 2023 (the
date which is 24 months from the closing date of the Company’s IPO), or such earlier date as determined by the Board, and to allow
the Board, without another shareholder vote, to extend the period of time to consummate the initial business combination for an additional
6 months after the Articles Extension Date on the same terms as the original extension right as contemplated by our IPO prospectus and
in accordance with the Articles, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination
Date, until May 23, 2024 (the date which is 30 months from the closing date of the Company’s IPO), or a total of twelve months
after May 23, 2023.
As a result of the Extraordinary General Meeting,
the Company’s shareholders redeemed 19,973,574 shares. As a result, $209,981,624 ($10.51 per share) was removed from the Company’s
trust account to pay such holders. Following redemptions, the Company has 151,426 Class A ordinary shares, subject to redemption outstanding.
On June 13, 2023, the Company received written
notification from the Nasdaq Stock Market, LLC (the “Exchange”) indicating that since the Company’s aggregate market
value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued
listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market value of its outstanding
warrants of at least $1 million (the “Notice”).
On June 30, 2023, the Company received a written
notice from the Listing Qualifications Department of Nasdaq indicating that the Company’s securities (units, ordinary shares, warrants,
and rights) would be subject to suspension and delisting from The Nasdaq Global Market at the opening of business on July 11, 2023 due
to the Company’s non-compliance with certain Nasdaq Listing Rules. On July 27, 2023, the Company received a written notice from the Listing Qualifications Department of Nasdaq stating that the
Company’s securities (units, ordinary shares, warrants, and rights) have been delisted from The Nasdaq Global Market due to the
Company’s non-compliance with certain Nasdaq Listing Rules. As a result, the Company’s securities trade on the OTC Market.
Results of Operation
We have neither engaged in any operations nor
generated any revenues to date. Our only activities for the three and nine months ended September 30, 2023 were organizational activities,
those necessary to prepare for our search for a target business with which to complete a Business Combination. We do not expect to generate
any operating revenues until after the completion of our initial business combination. We generate non-operating income in the form of
interest income on cash and cash equivalents held after the initial public offering. We incur expenses as a result of being a public
company (for legal, financial reporting, accounting and auditing compliance), as well as due diligence expenses in connection with completing
a Business Combination.
For the three months ended September 30, 2023,
we had net income of $734,361, which resulted from gain on marketable securities, along with interest and dividends of $25,321, a gain
on the change in fair value of derivative warrant liabilities of $895,414, and other income of $13, partially offset by formation and
operating costs of $186,387.
For the three months ended September 30, 2022,
we had net income of $2,805,123, which resulted from a gain on the change in fair value of derivative warrant liabilities of $1,919,757,
unrealized gain on marketable securities (net) held in Trust Account of $1,031,071, and other income of $89, partially offset by formation
and operating costs of $145,794.
For the nine months ended September 30, 2023,
we had net income of $3,467,536, which resulted from gain on marketable securities, along with interest and dividends of $3,710,486,
a gain on the change in fair value of derivative warrant liabilities of $539,458, and other income of $217, partially offset by formation
and operating costs of $782,625.
For the nine months ended September 30, 2022, we had net income of
$12,841,165 which resulted from a gain on the change in fair value of derivative warrant liabilities of $12,101,744, unrealized gain
on marketable securities (net) held in Trust Account of $1,247,152, and other income of $133, partially offset by formation and operating
costs of $507,864.
Liquidity, Going Concern and Capital Resources
Following the closing of the IPO on November 23,
2021, an amount of $205,275,000 ($10.20 per Unit) comprised of $197,225,000 of the proceeds from the IPO and $8,050,000 of the proceeds
from the Private Placement were placed in a U.S.-based trust account (the “Trust Account”) at J.P. Morgan Chase Bank, N.A.
maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds
in the Trust Account that may be released to us to pay its expenses relating to the administration of the Trust Account, the proceeds
from the IPO held in the Trust Account will not be released until the earliest of (i) the consummation of the initial business combination
or (ii) the distribution of the Trust Account proceeds as described below. The remaining proceeds outside the Trust Account may be used
to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses.
For the nine months ended September 30, 2023,
net cash used in operating activities was $564,205, which was due to gain on marketable securities (net) held in Trust Account of $3,710,486
and a change in fair value of derivative warrant liabilities of $539,458, partially offset by changes in working capital of $218,203,
and net income of $3,467,536.
For the nine months ended September 30, 2022,
net cash used in operating activities was $264,279, which was due to a change in fair value of derivative warrant liabilities of $12,101,744,
gain on marketable securities (net) held in Trust Account of $1,247,152, partially offset by net income of $12,841,165 and changes in
working capital of $243,452.
For the nine months ended September 30, 2023,
net cash provided by investing activities was $209,981,624, which was due to cash being withdrawn from trust account for payment to redeeming
shareholders.
There were no cash flows from investing activities
for the nine months ended September 30, 2022.
For the nine months ended September 30, 2023, net cash used in financing
activities was $209,983,606, which was due to the redemption of Class A ordinary shares of $209,981,624 and repayments of promissory
note – related party of $1,982.
For the nine months ended September 30, 2022,
net cash used in operating activities was $10,561, which was due to repayments of promissory note – related party.
As of September 30, 2023, we had cash and
marketable securities, along with interest and dividends earned, held in the Trust Account of $1,971,740 consisting of securities held
in a money market fund that invests in U.S. government treasury obligations with a maturity of 180 days or less. Interest income on the
balance in the Trust Account may be used by us to pay dissolution costs. Through September 30, 2023, we did not withdraw any interest
earned on the Trust Account to pay dissolution costs.
We intend to use substantially all of the funds
held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable and deferred underwriting
commissions), to complete our initial business combination. We may withdraw interest income (if any) to pay taxes. Our annual income
tax obligations will depend on the amount of interest and other income earned on the amounts held in the Trust Account. We expect the
interest income earned on the amount in the Trust Account (if any) will be sufficient to pay our taxes. To the extent that our equity
or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the
Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.
As of September 30, 2023 and December 31,
2022, we had cash of $52,704 and $618,891, respectively, held outside the Trust Account. We intend to use the funds held outside the
Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses,
travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review
corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
We do not believe we will need to raise additional
funds following the IPO in order to meet the expenditures required for operating our business prior to our initial business combination,
other than funds available from loans from our Sponsor, its affiliates or members of our management team. However, if our estimates of
the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less
than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business
combination. In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business
combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan
us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of
the trust account released to us. In the event that our initial business combination does not close, we may use a portion of the working
capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment.
Up to $2,100,000 of such loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant
at the option of the lender. The warrants would be identical to the private placement warrants. The terms of such loans, if any, have
not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination,
we do not expect to seek loans from parties other than our Sponsor, its affiliates or our management team as we do not believe third
parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
As of September 30, 2023, we had a working
capital deficit of $204,269.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, our Sponsor, or an affiliate of our Sponsor or certain of our
officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would
repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held
outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment. Up to
$2,100,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant unit at the option of the lender. The warrants
would be identical to the Private Placement Warrants. As of September 30, 2023 and December 31, 2022, there were no amounts
outstanding under any working capital loans.
We have incurred and expect to incur significant
costs in pursuit of its financing and acquisition plans. In connection with our assessment of going concern considerations, management
has determined that both our liquidity and liquidation deadline raise substantial doubt about our ability to continue as a going concern
within one year from the date that the financial statements are issued. There is no assurance that our plans to consummate a Business
Combination or raise additional funds will be successful within the Combination Period. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
Off-Balance Sheet Arrangements
We did not have any off-balance sheet arrangements as of September 30,
2023 and December 31, 2022.
Contractual Obligations
Registration Rights
The holders of founder shares, private placement
warrants, Class A ordinary shares underlying the private placement warrants and warrants that may be issued upon conversion of working
capital loans (and any Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be
issued upon conversion of working capital loans) are entitled to registration rights pursuant to a registration rights agreement. The
holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities.
These holders are entitled to certain demand and “piggyback” registration rights. We will bear the expenses incurred in connection
with the filing of any such registration statements.
Underwriting Agreement
We granted the underwriters a 45-day option from
the final prospectus relating to the IPO to purchase up to 2,625,000 additional units to cover over-allotments, if any, at the IPO price
less the underwriting discounts and commissions. On November 23, 2021, the underwriters fully exercised their over-allotment option.
Critical Accounting Policies and Estimates
The preparation of financial statements and related
disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date
of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.
We have identified the following critical accounting policies.
Class A Ordinary Shares Subject to Possible
Redemption
All of the 20,125,000 Class A ordinary shares
sold as part of the units in our initial public offering contain a redemption feature which allows for the redemption of such public
shares in connection with the our liquidation, if there is a shareholder vote or tender offer in connection with the business combination
and in connection with certain amendments to the amended and restated memorandum and articles of association. In accordance with SEC
and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not
solely within the control of us require ordinary shares subject to redemption to be classified outside of permanent equity. Therefore,
all Class A ordinary shares have been classified outside of permanent equity.
We recognize changes in redemption value immediately
as they occur and adjust the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting
period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in
capital (to the extent available) and accumulated deficit. The redemption value of the redeemable ordinary shares as of September 30,
2023 increased as the income earned on the trust account exceeds the Company’s expected dissolution expenses (up to $100,000).
As such, the Company recorded an increase in the carrying amount of the redeemable ordinary shares of $3,710,486 for the nine months
ended September 30, 2023.
Net Income Per Ordinary Share
Net income per ordinary share is computed by
dividing net income by the weighted-average number of ordinary shares outstanding during the period. The net income per share calculation
allocates income and losses shared pro rata between Class A and Class B ordinary shares. As a result, the calculated net income per share
is the same for Class A and Class B ordinary shares. The remeasurement of Class A ordinary shares subject to redemption to redemption
value is excluded from the earnings per share as the redemption value approximates fair value. Class B ordinary shares subject to forfeiture
are not considered in the calculation of diluted income per share until the forfeiture contingency has lapsed. The Company has not considered
the effect of the Public Warrants (as defined in Note 3) and Private Placement Warrants to purchase an aggregate of 20,212,500 shares
in the calculation of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events.
Warrant Liabilities
We account for warrants as either equity-classified
or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance
in ASC 480 and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are
freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants
meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary
shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated
fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the public warrants
and private placement warrants issued in connection with the initial public offering was measured at fair value using a Monte Carlo simulation
model.
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.
JOBS Act
The JOBS Act contains provisions that, among
other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company”
and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private
(not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may
not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging
growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting
pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating
the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth
in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an independent registered public accounting firm’s attestation report on our system of internal controls
over financial reporting pursuant to Section 404 of the Sarbanes Oxley Act (ii) provide all of the compensation disclosure that may be
required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with
any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the report of the independent
registered public accounting firm providing additional information about the audit and the financial statements (auditor discussion and
analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and
performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period
of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk.
The net proceeds from our initial public offering
and the sale of the private placement warrants held in the Trust Account is invested in U.S. government treasury obligations with a maturity
of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest
only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated
material exposure to interest rate risk.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls
and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the
Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our principal executive
officer and principal financial and accounting officer, to allow timely decisions regarding required disclosure.
As of September 30, 2023, as required by
Rules 13a-15 and 15d-15 under the Exchange Act, our principal executive officer and principal financial and accounting officer carried
out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation,
our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act) were effective.
Changes in Internal Control over Financial
Reporting
During the most recently completed fiscal quarter,
there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
There is no material litigation, arbitration
or governmental proceeding currently pending against us or any members of our management team in their capacity as such.
Item 1A. Risk Factors.
Factors that could cause our actual results to
differ materially from those in this Quarterly Report are any of the risks described in the Company’s annual report on Form 10-K
as filed with the SEC on April 14, 2023. Any of these factors could result in a significant or material adverse effect on our results
of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also
impair our business or results of operations. Except as set forth below, as of the date of this Quarterly Report, there have been no
material changes to the risk factors disclosed in the Company’s annual report on Form 10-K as filed with the SEC on April 14, 2023.
We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
A future potential
business combination may be subject to U.S. foreign investment regulations, including regulations relating to the Committee on Foreign
Investment in the United States, which may, among other things, impose conditions on, delay or prevent the consummation of such future
potential business combination, if any.
We are currently not aware
of any material regulatory approvals, clearances or actions that would be required for completion of a future potential business combination.
However, if any such approvals, clearances or actions were required, there can be no assurance that any such approval or clearance would
be obtained, or any such action taken, within the required time period. This includes any potential review of a future business combination,
if any, by a U.S. government entity, such as the Committee on Foreign Investment in the United States (“CFIUS”) on account
of certain restrictions on the acquisition of, or an investment in, a U.S. business by non-U.S. investors. If a potential business combination
falls within CFIUS’s jurisdiction to review the transaction in order to determine the effect of such transactions on the national
security of the U.S., we may be required to make a mandatory filing or we may determine to submit a voluntary notice to CFIUS, or we
may determine to proceed with such potential business combination without notifying CFIUS and risk CFIUS intervention, before or after
closing such potential business combination. CFIUS can contact parties to transactions within its jurisdiction that did not notify CFIUS
and request that the parties submit a CFIUS notice and can self-initiate national security reviews. If a potential business combination
falls within the scope of foreign ownership restrictions, CFIUS may impose conditions or limitations on such potential business combination
or we may be prevented from, or be unable to, consummate such potential business combination, if any.
Whether CFIUS has jurisdiction
to review an acquisition or investment transaction depends on, among other factors, (i) whether the investor/acquiror of the U.S. business
is a “foreign person” or “foreign entity,” (ii) the nature and structure of the transaction, (iii) the
level of beneficial ownership interest, and (iv) the nature of any information or governance rights involved. Some transactions within
the jurisdiction of CFIUS trigger a mandatory CFIUS filing requirement. Otherwise, notifying CFIUS of a transaction within its jurisdiction
is voluntary. For example, investments that result in “control” of a “U.S. business” by a “foreign person”
(in each case, as such terms are defined in 31 C.F.R. Part 800) are always subject to CFIUS jurisdiction. The Foreign Investment Risk
Review Modernization Act of 2018, which was fully implemented through regulations that became effective in 2020, significantly expanded
the scope of CFIUS’s jurisdiction to investments that do not result in control of a U.S. business by a foreign person, but afford
certain foreign investors certain information or governance rights in a U.S. business that has a nexus to “critical technologies,”
“covered investment critical infrastructure,” and/or “sensitive personal data” (in each case, as such terms are
defined in 31 C.F.R. Part 800).
Our Sponsor is controlled
by, and have substantial ties with, non-U.S. persons. Our Sponsor is a limited liability company formed and registered under the laws
of the Cayman Islands and is controlled by a board of managers, who are non-U.S. persons. For further information, see “Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” of our annual report on Form 10-K.
While we and our Sponsor, are controlled by, and have substantial ties with non-U.S. persons, we believe that it is unlikely that any
of the facts or relationships with respect to a potential future business combination that we may pursue, would subject such potential
business combination to regulatory review by a U.S. government entity or authority, including review by CFIUS. Nor do we believe that
a potential future business combination would ultimately be prohibited if such review was conceivable.
However, there can be no
assurances that CFIUS or another U.S. governmental agency will not take a different view of a potential business combination or will
not choose to review such potential business combination, if any. If a potential business combination falls within CFIUS’s jurisdiction,
we may be required to make a mandatory filing or determine to submit a voluntary notice to CFIUS, or to proceed with such potential business
combination without notifying CFIUS and risk CFIUS intervention, before or after the consummation of such potential business combination.
In addition, for so long as the Sponsor retains a material ownership interest in the Company, the Company may be deemed a “foreign
person” under the regulations relating to CFIUS and any potential initial business combination with a U.S. business or foreign
business with U.S. subsidiaries that the Company may wish to pursue may be subject to CFIUS review. In connection with a potential business
combination, CFIUS could, among other things, (i) decide to block or delay such potential business combination, (ii) impose conditions,
limitations or restrictions with respect to such potential business combination (including, but not limited to, limits on information
sharing with investors, requiring a voting trust, governance modifications, or forced divestiture, among other things), or (iii) request
the President of the United States to order the Company to divest all or a portion of any U.S. target business of such potential business
combination that the Company acquired without first obtaining CFIUS clearance. In addition, CFIUS may impose penalties if CFIUS believes
that the mandatory notification requirement applied to such potential business combination. The risk of review by CFIUS may force our
management to limit the pool of potential target companies to companies that our management believes are not subject to CFIUS’s
jurisdiction, in which case the Company’s ability to find a target may be limited. In this regard please also see “Risk Factors—Risks
Relating to Our Search for, and Consummation of or Inability to Consummate, a Business Combination—Because of our limited resources
and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business
combination. If we are unable to complete our initial business combination within the required time period, our public shareholders may
receive only their pro rata portion of the funds in the trust account that are available for distribution to public shareholders, and
our warrants will expire worthless.”
The process of government
review, whether by CFIUS or otherwise, could be lengthy. If we are unable to consummate a potential business combination within 30 months
from the Company’s initial public offering (i.e., May 23, 2024) as extended in accordance with the terms described in our amended
and restated memorandum and articles of association, as amended), we would, as promptly as reasonably possible but not more than ten
business days thereafter, redeem the public shares then outstanding, at a per-share price, payable in cash, equal to the aggregate amount
then on deposit in the trust account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest
shall be net of taxes payable), divided by the number of then outstanding public shares, which redemption will completely extinguish
public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject
to applicable law. In such event, the Company’s shareholders would miss the opportunity to benefit from an investment in any other
target company in an initial business combination and the appreciation in value of such investments. Additionally, the Company’s
warrants would expire worthless.
In addition, CFIUS could choose to review past
or proposed transactions involving new or existing foreign investors in the Company or in the Sponsor, even if a filing with CFIUS is
or was not required at the time of the potential business combination. Any review and clearance of an investment or transaction by CFIUS
may have outsized impacts on transaction certainty, timing, feasibility, and cost, among other things. CFIUS policies and agency practices
are rapidly evolving, and, in the event that CFIUS reviews a potential business combination or one or more proposed or existing investments
by investors, there can be no assurances that such investors will be able to maintain, or proceed with, such investments on terms acceptable
to the parties to such potential business combination or such investors.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
The following exhibits are
filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
| ** | These certifications are
furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed
not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
nor shall they be deemed incorporated by reference in any filing under the Securities Act
of 1933, except as shall be expressly set forth by specific reference in such filing. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 8, 2023.
|
Crescera Capital Acquisition Corp. |
|
|
|
|
By: |
/s/ Felipe
Samuel Argalji |
|
|
Name: Felipe Samuel
Argalji |
|
|
Title: Chief Executive
Officer |
31
00-0000000
10247958
20125000
20125000
151426
0.10
0.11
0.20
0.48
6708333
6708333
6708333
6708333
0.10
0.11
0.20
0.48
20125000
6708333
6708333
151426
0.10
0.10
0.11
0.11
10247958
20125000
6708333
6708333
0.20
0.20
0.48
0.48
false
--12-31
Q3
0001851230
0001851230
2023-01-01
2023-09-30
0001851230
crec:ClassAOrdinarySharesParValue00001PerShareMember
2023-01-01
2023-09-30
0001851230
crec:RedeemableWarrantsEachOneWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member
2023-01-01
2023-09-30
0001851230
crec:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember
2023-01-01
2023-09-30
0001851230
us-gaap:CommonClassAMember
2023-11-08
0001851230
us-gaap:CommonClassBMember
2023-11-08
0001851230
2023-09-30
0001851230
2022-12-31
0001851230
us-gaap:RelatedPartyMember
2023-09-30
0001851230
us-gaap:RelatedPartyMember
2022-12-31
0001851230
us-gaap:CommonClassAMember
2023-09-30
0001851230
us-gaap:CommonClassAMember
2022-12-31
0001851230
us-gaap:CommonClassBMember
2023-09-30
0001851230
us-gaap:CommonClassBMember
2022-12-31
0001851230
2023-07-01
2023-09-30
0001851230
2022-07-01
2022-09-30
0001851230
2022-01-01
2022-09-30
0001851230
us-gaap:CommonClassAMember
2023-07-01
2023-09-30
0001851230
us-gaap:CommonClassAMember
2022-07-01
2022-09-30
0001851230
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001851230
us-gaap:CommonClassAMember
2022-01-01
2022-09-30
0001851230
us-gaap:CommonClassBMember
2023-07-01
2023-09-30
0001851230
us-gaap:CommonClassBMember
2022-07-01
2022-09-30
0001851230
us-gaap:CommonClassBMember
2023-01-01
2023-09-30
0001851230
us-gaap:CommonClassBMember
2022-01-01
2022-09-30
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2022-12-31
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001851230
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001851230
us-gaap:RetainedEarningsMember
2022-12-31
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2023-01-01
2023-03-31
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001851230
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001851230
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001851230
2023-01-01
2023-03-31
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2023-03-31
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001851230
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001851230
us-gaap:RetainedEarningsMember
2023-03-31
0001851230
2023-03-31
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2023-04-01
2023-06-30
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001851230
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001851230
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001851230
2023-04-01
2023-06-30
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2023-06-30
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-06-30
0001851230
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001851230
us-gaap:RetainedEarningsMember
2023-06-30
0001851230
2023-06-30
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2023-07-01
2023-09-30
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0001851230
us-gaap:AdditionalPaidInCapitalMember
2023-07-01
2023-09-30
0001851230
us-gaap:RetainedEarningsMember
2023-07-01
2023-09-30
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2023-09-30
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-09-30
0001851230
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0001851230
us-gaap:RetainedEarningsMember
2023-09-30
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2021-12-31
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-12-31
0001851230
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001851230
us-gaap:RetainedEarningsMember
2021-12-31
0001851230
2021-12-31
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2022-01-01
2022-03-31
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001851230
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0001851230
us-gaap:RetainedEarningsMember
2022-01-01
2022-03-31
0001851230
2022-01-01
2022-03-31
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2022-03-31
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-03-31
0001851230
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001851230
us-gaap:RetainedEarningsMember
2022-03-31
0001851230
2022-03-31
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2022-04-01
2022-06-30
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001851230
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0001851230
us-gaap:RetainedEarningsMember
2022-04-01
2022-06-30
0001851230
2022-04-01
2022-06-30
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2022-06-30
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-06-30
0001851230
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001851230
us-gaap:RetainedEarningsMember
2022-06-30
0001851230
2022-06-30
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2022-07-01
2022-09-30
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001851230
us-gaap:AdditionalPaidInCapitalMember
2022-07-01
2022-09-30
0001851230
us-gaap:RetainedEarningsMember
2022-07-01
2022-09-30
0001851230
us-gaap:CommonClassAMember
crec:OrdinarySharesSubjectToPossibleRedemptionMember
2022-09-30
0001851230
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-09-30
0001851230
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0001851230
us-gaap:RetainedEarningsMember
2022-09-30
0001851230
2022-09-30
0001851230
us-gaap:NASDAQIndexFutureMember
2023-06-13
0001851230
us-gaap:WarrantMember
2023-06-13
0001851230
us-gaap:IPOMember
2021-11-23
2021-11-23
0001851230
us-gaap:OverAllotmentOptionMember
2021-11-23
2021-11-23
0001851230
us-gaap:OverAllotmentOptionMember
2021-11-23
0001851230
us-gaap:CommonClassAMember
us-gaap:OverAllotmentOptionMember
2021-11-23
2021-11-23
0001851230
us-gaap:PrivatePlacementMember
2023-09-30
0001851230
us-gaap:PrivatePlacementMember
2023-01-01
2023-09-30
0001851230
us-gaap:PrivatePlacementMember
2021-11-23
2021-11-23
0001851230
us-gaap:PrivatePlacementMember
2021-11-23
0001851230
us-gaap:IPOMember
2023-09-30
0001851230
crec:SponsorMember
2023-09-30
0001851230
us-gaap:WarrantMember
2023-09-30
0001851230
crec:OrdinarySharesSubjectToPossibleRedemptionClassAMember
2022-12-31
0001851230
crec:OrdinarySharesSubjectToPossibleRedemptionClassAMember
2023-01-01
2023-03-31
0001851230
crec:OrdinarySharesSubjectToPossibleRedemptionClassAMember
2023-03-31
0001851230
crec:OrdinarySharesSubjectToPossibleRedemptionClassAMember
2023-04-01
2023-06-30
0001851230
crec:OrdinarySharesSubjectToPossibleRedemptionClassAMember
2023-06-30
0001851230
crec:OrdinarySharesSubjectToPossibleRedemptionClassAMember
2023-07-01
2023-09-30
0001851230
crec:OrdinarySharesSubjectToPossibleRedemptionClassAMember
2023-09-30
0001851230
us-gaap:IPOMember
2023-01-01
2023-09-30
0001851230
us-gaap:OverAllotmentOptionMember
2023-01-01
2023-09-30
0001851230
us-gaap:OverAllotmentOptionMember
2023-09-30
0001851230
us-gaap:CommonClassAMember
us-gaap:PrivatePlacementMember
2023-09-30
0001851230
crec:FounderShareMember
2021-03-31
2021-03-31
0001851230
crec:FounderShareMember
us-gaap:CommonClassBMember
2021-03-31
2021-03-31
0001851230
crec:FounderShareMember
2021-10-31
2021-10-31
0001851230
crec:FounderShareMember
2021-10-31
0001851230
crec:SponsorMember
2021-10-31
2021-10-31
0001851230
crec:FounderShareMember
crec:SponsorMember
2023-01-01
2023-09-30
0001851230
crec:SponsorMember
2023-01-01
2023-09-30
0001851230
crec:FounderShareMember
2023-09-30
0001851230
crec:FounderShareMember
us-gaap:CommonClassAMember
2023-09-30
0001851230
crec:FounderShareMember
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001851230
crec:FounderShareMember
crec:SponsorMember
2023-01-01
2023-09-30
0001851230
crec:FounderShareMember
crec:SponsorMember
2023-09-30
0001851230
crec:FounderShareMember
2023-01-01
2023-09-30
0001851230
crec:ConvertedBasisMember
crec:FounderShareMember
2023-01-01
2023-09-30
0001851230
crec:SponsorMember
us-gaap:IPOMember
2023-09-30
0001851230
crec:PrivatePlacementWarrantsMember
2023-09-30
0001851230
crec:UnderwritersMember
2023-09-30
0001851230
crec:PublicWarrantMember
2023-09-30
0001851230
crec:BusinessCombinationMember
2023-01-01
2023-09-30
0001851230
us-gaap:WarrantMember
2023-01-01
2023-09-30
0001851230
srt:MinimumMember
2023-01-01
2023-09-30
0001851230
srt:MaximumMember
2023-01-01
2023-09-30
0001851230
srt:MinimumMember
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001851230
srt:MaximumMember
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001851230
crec:ClassACommonStockEqualsOrExceedsThresholdOneMember
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001851230
crec:ClassACommonStockEqualsOrExceedsThresholdOneMember
us-gaap:CommonClassAMember
2023-09-30
0001851230
crec:ClassACommonStockEqualsOrExceedsThresholdTwoMember
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001851230
crec:ClassACommonStockEqualsOrExceedsThresholdTwoMember
us-gaap:CommonClassAMember
2023-09-30
0001851230
us-gaap:FairValueInputsLevel1Member
2023-09-30
0001851230
us-gaap:FairValueInputsLevel2Member
2023-09-30
0001851230
us-gaap:FairValueInputsLevel3Member
2023-09-30
0001851230
crec:PublicWarrantsMember
2023-09-30
0001851230
us-gaap:FairValueInputsLevel1Member
crec:PublicWarrantsMember
2023-09-30
0001851230
us-gaap:FairValueInputsLevel2Member
crec:PublicWarrantsMember
2023-09-30
0001851230
us-gaap:FairValueInputsLevel3Member
crec:PublicWarrantsMember
2023-09-30
0001851230
us-gaap:FairValueInputsLevel1Member
us-gaap:PrivatePlacementMember
2023-09-30
0001851230
us-gaap:FairValueInputsLevel2Member
us-gaap:PrivatePlacementMember
2023-09-30
0001851230
us-gaap:FairValueInputsLevel3Member
us-gaap:PrivatePlacementMember
2023-09-30
0001851230
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001851230
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001851230
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001851230
crec:PublicWarrantsMember
2022-12-31
0001851230
us-gaap:FairValueInputsLevel1Member
crec:PublicWarrantsMember
2022-12-31
0001851230
us-gaap:FairValueInputsLevel2Member
crec:PublicWarrantsMember
2022-12-31
0001851230
us-gaap:FairValueInputsLevel3Member
crec:PublicWarrantsMember
2022-12-31
0001851230
us-gaap:PrivatePlacementMember
2022-12-31
0001851230
us-gaap:FairValueInputsLevel1Member
us-gaap:PrivatePlacementMember
2022-12-31
0001851230
us-gaap:FairValueInputsLevel2Member
us-gaap:PrivatePlacementMember
2022-12-31
0001851230
us-gaap:FairValueInputsLevel3Member
us-gaap:PrivatePlacementMember
2022-12-31
0001851230
2022-01-01
2022-12-31
0001851230
us-gaap:FairValueInputsLevel3Member
2021-12-31
0001851230
us-gaap:FairValueInputsLevel3Member
2022-01-01
2022-03-31
0001851230
us-gaap:FairValueInputsLevel3Member
2022-03-31
0001851230
us-gaap:FairValueInputsLevel3Member
2022-04-01
2022-06-30
0001851230
us-gaap:FairValueInputsLevel3Member
2022-06-30
0001851230
us-gaap:FairValueInputsLevel3Member
2022-07-01
2022-09-30
0001851230
us-gaap:FairValueInputsLevel3Member
2022-09-30
0001851230
us-gaap:FairValueInputsLevel3Member
2022-10-01
2022-12-31
0001851230
us-gaap:FairValueInputsLevel3Member
2023-01-01
2023-03-31
0001851230
us-gaap:FairValueInputsLevel3Member
2023-03-31
0001851230
us-gaap:FairValueInputsLevel3Member
2023-04-01
2023-06-30
0001851230
us-gaap:FairValueInputsLevel3Member
2023-06-30
0001851230
us-gaap:FairValueInputsLevel3Member
2023-07-01
2023-09-30
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Quarterly Report of
Crescera Capital Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I, Felipe Samuel Argalji, Chief Executive
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to my knowledge:
In connection with the Quarterly Report of
Crescera Capital Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I, Rafael Pereira, Chief Financial Officer of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to my knowledge: